Category: Insulet Corp.Syndicate content

Medtech leaders talk mistakes, challenges and opportunities at DeviceTalks

July 16, 2014 by Arezu Sarvestani

Top execs from Haemonetics, Kips Bay and others open up about their biggest regrets, debate market pressures facing the medtech industry and offer advice for young entrepreneurs.

Medtech CEOs talk mistakes, challenges and opportunities at DeviceTalks

A group of medtech insiders gathered in Boston last night to talk shop, share stories and glean insight from some of the industry's brightest minds at MassDevice's DeviceTalks East conference.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Insulet settles Becton, Dickinson patent spat for $5M

June 30, 2014 by Brad Perriello

Insulet says it agreed to settle a patent infringement lawsuit brought by Becton, Dickinson for $5 million.

Diabetes: Insulet settles Becton, Dickinson patent spat for $5M

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Insulet, DexCom rekindle partnership with mobile app for OmniPod

June 17, 2014 by Arezu Sarvestani

After breaking up last year, Insulet and DexCom come together again to integrate insulin pump devices with mobile apps that aggregate and display important data for patients with diabetes.

Diabetes: Insulet, DexCom rekindle partnership with mobile app for OmniPod

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Abbott recalls blood glucose meters over false readings

March 17, 2014 by Arezu Sarvestani

Abbott Diabetes Care recalls FreeStyle and FreeStyle Flash blood glucose meters users over concerns that the devices may report erroneously low readings.

Updated March 17, 2014, at 4:30 pm. with comments from Abbott.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Insulet boosts sales, slashes losses, notes Mass. state inquiry

February 28, 2014 by Arezu Sarvestani

Diabetes devices maker Insulet posts a stellar quarter that beats Wall Street's expectations and notes a pending Massachusetts Attorney General inquiry.

Diabetes: Insulet gains on boost in sales, narrowing losses in Q4 and 2013

Massachusetts-based Insulet (NSDQ:PODD) got some Wall Street love today after posing a significant bump in sales for its 4th quarter and the full year of 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Insulet expands into new HQ

February 10, 2014 by Chris Walker

Insulet plans an expansion into new headquarters, moving from Bedford, Mass., to nearby Billerica.

Insulet moving HQ down the street

Insulet (NSDQ:PODD) is moving its corporate headquarters to Billerica, Mass., 9 minutes away from the company's current home in Bedford, Mass.

Diabetes: Insulet to hire 20 new sales reps as pediatric pump sales soar

January 16, 2014 by Arezu Sarvestani

Insulin pump maker Insulet plans to add another 20 sales reps to its team by the end of Q1, as the company continues to see major growth in pediatric users of its tubeless OmniPod system.

Diabetes: Insulet to hire 20 new sales reps as pediatric pump sales soar

Insulet (NSDQ:PODD) president & CEO Duane DeSisto is looking for a few good reps, planning to add 20 members to the company's sales force by the end of the 1st quarter.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp